A new study confirms that dietary patterns like the Mediterranean diet and the MIND diet and suggest that inflammatory diets may increase someone's chances of developing dementia.

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.

Cipla celebrates 90 years with focus on quality products, global presence, and investment in research and technology.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Among children ages 3 to 17, the "prevalence of chronic conditions increased from 39.9% to 45.7% in pediatric health systems ...

Estrogen-progestin hormone therapy used to manage menopausal symptoms and other women’s health conditions is associated with a higher risk of developing luminal-like breast cancer subtypes and other ...

Three patient outcomes were measured in this new study: time to onset of ocular-related myasthenia gravis, Activities of ...

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Patients with overweight or obesity and heart failure with preserved ejection fraction that have unintentional weight loss have worse outcomes.

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...